論文

本文へのリンクあり
2021年5月1日

Optimal management of the unilateral recurrent laryngeal nerve involvement in patients with thyroid cancer

Cancers
  • Satoru Miyamaru
  • ,
  • Daizo Murakami
  • ,
  • Kohei Nishimoto
  • ,
  • Narihiro Kodama
  • ,
  • Joji Tashiro
  • ,
  • Yusuke Miyamoto
  • ,
  • Haruki Saito
  • ,
  • Hiroki Takeda
  • ,
  • Momoko Ise
  • ,
  • Yorihisa Orita

13
9
記述言語
掲載種別
研究論文(学術雑誌)
DOI
10.3390/cancers13092129

We aimed to determine the optimal management of recurrent laryngeal nerve (RLN) involvement in thyroid cancer. We enrolled 80 patients with unilateral RLN involvement in thyroid cancer between 2000 and 2016. Eleven patients with preoperatively functional vocal folds (VFs) underwent sharp tumor resection to preserve the RLN (shaving group). Thirty‐three patients underwent RLN reconstruction with RLN resection (reconstruction group). We divided the reconstruction group into two subgroups based on preoperative VF mobility (nor-mal‐reconstruction and paralyzed‐reconstruction subgroups). In the cases where RLN reconstruction was difficult, phonosurgeries including arytenoid adduction (AA), with or without thyro-plasty type I, or nerve muscle pedicle implantation with AA were performed later (phonosurgery group). We evaluated and compared vocal function among the evaluated periods and different groups. Postoperative vocal function in the shaving and normal‐reconstruction subgroups was favorable. There were no significant differences between the two groups. In the para-lyzed‐reconstruction and phonosurgery groups, postoperative vocal function was significantly improved, and vocal function in the paralyzed‐reconstruction subgroup was significantly better than that in the phonosurgery group. For optimal management of unilateral RLN involvement in thyroid cancer, first, sharp dissection should be performed, and if this is impossible, a simultane-ous RLN reconstruction procedure should be adopted whenever possible.

リンク情報
DOI
https://doi.org/10.3390/cancers13092129
Scopus
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85104780023&origin=inward 本文へのリンクあり
Scopus Citedby
https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85104780023&origin=inward
ID情報
  • DOI : 10.3390/cancers13092129
  • eISSN : 2072-6694
  • SCOPUS ID : 85104780023

エクスポート
BibTeX RIS